• Philadelphia Pharma
  • Philadelphia Pharma Philadelphia Pharma
    • Home
    • About us
    • Therapeutic Areas
    • BLOG
    • News & Events
    • MEDIA
    • Register Now
    • Français
  • CONTACTEZ-NOUS

    Day: September 17, 2026

    • Home
    • 2026
    • September
    • 17

Anticoagulation for Atrial Fibrillation with intermediate stroke risk

  • September 17, 2026
  • philadelphia-pharma

Discover the results of the SINGLE-AF study, recently published in the New England Journal of Medicine, providing new data on the use of direct oral anticoagulants in..

  • Lire plus

Recent Posts

  • Anticoagulation for Atrial Fibrillation with intermediate stroke risk
  • 2026 AHA/ACC/ADA/ASN Guidelines for the management of Cardiorenal-Metabolic Syndrome
  • ACC/AHA 2026 Recommendations for the Management of Pulmonary Embolism
  • COMBAT-AF: Anticoagulants and Atrial Fibrillation
  • Clinical Studies

Categories

  • Clinical Studies
  • Guidelines
  • History of Medicine
  • Public Health
  • Research & Development
Direction médicale :

Philadelphia Promotion | Centre Urbain Nord - Immeuble Coral,
Avenue Zohra Faiza BLOC B - 10 EME ETAGE Tunis, 1082

Site industriel :

Philadelphia Pharma | Zone Industrielle – Km 4 Route de Sfax – 3000 Sfax, Tunisie

Contactez-nous

[email protected]
  • © Copyright 2025. All rights reserved. Philadelphia-Pharma

Philadelphia Pharma
  • Home
  • About us
  • Therapeutic Areas
  • BLOG
  • News & Events
  • MEDIA
  • Register Now
  • Français